Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/17272797
Conclusion of this study
Based on these results, ALA should be considered as a treatment option for patients with PDN. When discussing supplementation with patients, it is important to discuss potential side effects; vitamin, mineral, and drug interactions; and current evidence available regarding efficacy.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
